Incyclix Bio (Incyclix) is developing INX-315 as an oral, small molecule inhibitor of cyclin dependent kinase 2 (CDK2) for the treatment of human cancers. This…

Breast CancerBreast Cancer MetastaticHormone Receptor Positive Tumor+6 more

~Estimated

~$10 – $8,750

Incyclix BioNCT05735080

Phase 1

Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma

Testing an investigational cancer therapy called TGFBR-2 KO CD70 CAR NK cell therapy.

Clear Cell CarcinomaPhase 1Growth Factor

~Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT07072234

← PreviousPage 2 of 2Next →